194 related articles for article (PubMed ID: 11582574)
1. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
Stavrakoudis A; Bizos G; Eleftheriadis D; Kouki A; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tsikaris V
Biopolymers; 2000-2001; 56(1):20-6. PubMed ID: 11582574
[TBL] [Abstract][Full Text] [Related]
2. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
3. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
Müller G; Gurrath M; Kessler H
J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
[TBL] [Abstract][Full Text] [Related]
5. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT
J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.
O'Neil KT; Hoess RH; Jackson SA; Ramachandran NS; Mousa SA; DeGrado WF
Proteins; 1992 Dec; 14(4):509-15. PubMed ID: 1438188
[TBL] [Abstract][Full Text] [Related]
7. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
Andronati SA; Karaseva TL; Krysko AA
Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
[TBL] [Abstract][Full Text] [Related]
8. Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets.
Kouki A; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tselepis AD; Tsikaris V; Tsoukatos DC
J Thromb Haemost; 2005 Oct; 3(10):2324-30. PubMed ID: 16129021
[TBL] [Abstract][Full Text] [Related]
9. The relative orientation of the Arg and Asp side chains defined by a pseudodihedral angle as a key criterion for evaluating the structure-activity relationship of RGD peptides.
Kostidis S; Stavrakoudis A; Biris N; Tsoukatos D; Sakarellos C; Tsikaris V
J Pept Sci; 2004 Aug; 10(8):494-509. PubMed ID: 15347137
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD peptide analogues as antiplatelet antithrombotics.
Barker PL; Bullens S; Bunting S; Burdick DJ; Chan KS; Deisher T; Eigenbrot C; Gadek TR; Gantzos R; Lipari MT
J Med Chem; 1992 May; 35(11):2040-8. PubMed ID: 1597855
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of a cyclic RGD peptide that inhibits platelet aggregation.
Jois SD; Tambunan US; Chakrabarti S; Siahaan TJ
J Biomol Struct Dyn; 1996 Aug; 14(1):1-11. PubMed ID: 8877556
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of cyclic oligopeptides containing an Arg-Gly-Asp (RGD) sequence.
Sofuku S; Hoshida A; Shimada T; Takada Y; Takakuwa T
Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1799-801. PubMed ID: 10748723
[TBL] [Abstract][Full Text] [Related]
13. Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
Sugihara H; Fukushi H; Miyawaki T; Imai Y; Terashita Z; Kawamura M; Fujisawa Y; Kita S
J Med Chem; 1998 Feb; 41(4):489-502. PubMed ID: 9484499
[TBL] [Abstract][Full Text] [Related]
14. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA
J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
17. Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides.
Peishoff CE; Ali FE; Bean JW; Calvo R; D'Ambrosio CA; Eggleston DS; Hwang SM; Kline TP; Koster PF; Nichols A
J Med Chem; 1992 Oct; 35(21):3962-9. PubMed ID: 1433203
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and properties of peptidomimetics--inhibitors of platelet aggregation.
Andronati SA; Krysko AA; Kabanov VM; Karaseva TL; Kabanova TA
Acta Pol Pharm; 2000 Nov; 57 Suppl():15-21. PubMed ID: 11293251
[TBL] [Abstract][Full Text] [Related]
19. From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.
Blackburn BK; Lee A; Baier M; Kohl B; Olivero AG; Matamoros R; Robarge KD; McDowell RS
J Med Chem; 1997 Feb; 40(5):717-29. PubMed ID: 9057858
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists.
Cheng S; Craig WS; Mullen D; Tschopp JF; Dixon D; Pierschbacher MD
J Med Chem; 1994 Jan; 37(1):1-8. PubMed ID: 7507165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]